Lawrence P. Wennogle, Vice President, Drug Discovery at Intra-Cellular Therapies, Inc. (ITCI), sold 6,000 shares at $14.99 ($90K) on 2014-05-22, disclosed to the SEC on 2014-05-23.
Open-market sale of $90k ITCI by Vice President, Drug Discovery. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.99 | 1,694 | $25K | 28.2% |
| 2 | $15.00 | 4,306 | $65K | 71.8% |
| Total | $15.00 avg | 6,000 | $90K | 100% |
| Filing → |
| ITCI | SELL | 2014-10-15 | $54K | — | Filing → |
| ITCI | SELL | 2014-10-10 | $71K | — | Filing → |
| ITCI | SELL | 2014-10-07 | $247K | — | Filing → |